<?xml version="1.0" encoding="UTF-8"?>
<!--generator='jetpack-16.3.1'-->
<!--Jetpack_Sitemap_Buffer_News_XMLWriter-->
<?xml-stylesheet type="text/xsl" href="//www.bioredbrasil.com.br/news-sitemap.xsl"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd">
 <url>
  <loc>https://www.bioredbrasil.com.br/cns-prorroga-inscricoes-para-recomposicao-da-conep/</loc>
  <lastmod>2026-10-28T16:02:27Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Biored Brasil</news:name>
    <news:language>pt</news:language>
   </news:publication>
   <news:title>CNS prorroga inscrições para recomposição da Conep</news:title>
   <news:publication_date>2026-10-29T17:30:02Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://www.bioredbrasil.com.br/dia-mundial-da-psoriase-dermatologista-da-sbcd-explica-como-reconhecer-a-doenca-e-quais-cuidados-adotar/</loc>
  <lastmod>2026-10-29T14:19:33Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Biored Brasil</news:name>
    <news:language>pt</news:language>
   </news:publication>
   <news:title>Dia Mundial da Psoríase: dermatologista da SBCD explica como reconhecer a doença e quais cuidados adotar</news:title>
   <news:publication_date>2026-10-29T15:30:01Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://www.bioredbrasil.com.br/dia-da-psoriase-tratamentos-inovadores-avancam-nos-ultimos-20-anos/</loc>
  <lastmod>2026-10-28T14:32:15Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Biored Brasil</news:name>
    <news:language>pt</news:language>
   </news:publication>
   <news:title>Dia da Psoríase: tratamentos inovadores avançam nos últimos 20 anos</news:title>
   <news:publication_date>2026-10-29T13:30:35Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://www.bioredbrasil.com.br/oncoguia-lanca-guia-para-orientar-pacientes-com-cancer-sobre-uso-seguro-da-inteligencia-artificial/</loc>
  <lastmod>2026-10-19T19:41:23Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Biored Brasil</news:name>
    <news:language>pt</news:language>
   </news:publication>
   <news:title>Oncoguia lança guia para orientar pacientes com câncer sobre uso seguro da inteligência artificial</news:title>
   <news:publication_date>2026-10-29T13:30:00Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://www.bioredbrasil.com.br/cns-abre-consulta-publica-sobre-regras-da-etapa-nacional-da-18a-conferencia-nacional-de-saude/</loc>
  <lastmod>2026-10-28T15:42:42Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Biored Brasil</news:name>
    <news:language>pt</news:language>
   </news:publication>
   <news:title>CNS abre consulta pública sobre regras da Etapa Nacional da 18ª Conferência Nacional de Saúde</news:title>
   <news:publication_date>2026-10-28T21:30:01Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://www.bioredbrasil.com.br/cosaude-debate-quatro-tecnologias-para-tratamento-de-cancer-doencas-pulmonares-biliares-e-deficiencia-hormonal/</loc>
  <lastmod>2026-10-28T15:11:42Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Biored Brasil</news:name>
    <news:language>pt</news:language>
   </news:publication>
   <news:title>Cosaúde debate quatro tecnologias para tratamento de câncer, doenças pulmonares, biliares e deficiência hormonal</news:title>
   <news:publication_date>2026-10-28T19:30:43Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://www.bioredbrasil.com.br/cosaude-mantem-analise-desfavoravel-a-quatro-tecnologias-e-inicia-discussao-de-outras-duas-em-sua-reuniao-tecnica/</loc>
  <lastmod>2026-10-28T14:51:26Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Biored Brasil</news:name>
    <news:language>pt</news:language>
   </news:publication>
   <news:title>Cosaúde mantém análise desfavorável a quatro tecnologias e inicia discussão de outras duas em sua Reunião Técnica</news:title>
   <news:publication_date>2026-10-28T15:30:19Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://www.bioredbrasil.com.br/descontinuacao-de-remedio-para-epilepsia-preocupa-medicos-e-pacientes/</loc>
  <lastmod>2026-10-19T19:35:43Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Biored Brasil</news:name>
    <news:language>pt</news:language>
   </news:publication>
   <news:title>Descontinuação de remédio para epilepsia preocupa médicos e pacientes</news:title>
   <news:publication_date>2026-10-28T13:30:20Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://www.bioredbrasil.com.br/anvisa-autoriza-testes-em-humanos-de-vacina-brasileira-contra-malaria/</loc>
  <lastmod>2026-10-19T19:26:43Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Biored Brasil</news:name>
    <news:language>pt</news:language>
   </news:publication>
   <news:title>Anvisa autoriza testes em humanos de vacina brasileira contra malária</news:title>
   <news:publication_date>2026-10-27T13:30:37Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
</urlset>
